BMRN:VIE
Biomarin Pharmaceutical Inc
€45.96
arrow_downward
-1.05%(-0.49) 1D
Jun 3, 11:00:43 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMRN...
Open
€45.90
High
€45.96
Low
€45.90
Mkt. cap
10.31B
Avg. vol.
34.00
Volume
0.00
52-wk high
€55.94
52-wk low
€42.77
Shares outstanding
178.06M
No. of employees
3K
Open
€45.90
High
€45.96
Low
€45.90
Mkt. cap
10.31B
Avg. vol.
34.00
Volume
0.00
52-wk high
€55.94
52-wk low
€42.77
Shares outstanding
178.06M
No. of employees
3K
News stories
From sources across the web
Profile
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
About Biomarin Pharmaceutical Inc
CEOAlexander Hardy
Employees3.22K
FoundedMar 1997
HeadquartersSan Rafael, California, United States
SectorBiotechnology
Websitebiomarin.com
AI content may include mistakes. Learn more